A
Alok C. Bharti
Researcher at University of Delhi
Publications - 102
Citations - 8483
Alok C. Bharti is an academic researcher from University of Delhi. The author has contributed to research in topics: Cancer & Cervical cancer. The author has an hindex of 38, co-authored 95 publications receiving 7744 citations. Previous affiliations of Alok C. Bharti include Indian Council of Medical Research & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host.
TL;DR: The findings of the present investigation indicate that aspirin administration to male and female tumor-bearing hosts resulted in gender dependent differential tumor growth retardation and should be considered in designing of gender-specific therapeutic applications of aspirin.
Journal ArticleDOI
Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer
TL;DR: Monitoring of plasma VEGF levels during the course of first-line chemotherapy could identify patients who are likely to have insufficient response to therapy and disease progression at an early stage to help in individualizing treatment and could lead to better management of the advanced stage lung cancer.
Journal ArticleDOI
Level of phospho-STAT3 (Tyr705) correlates with copy number and physical state of human papillomavirus 16 genome in cervical precancer and cancer lesions
Shirish Shukla,Mohit Jadli,Kulbhushan Thakur,Gauri Shishodia,Sutapa Mahata,Seemi Farhat Basir,Bhudev C. Das,Alok C. Bharti,Alok C. Bharti +8 more
TL;DR: The study suggests that there exists a strong clinical correlation between level of active STAT3 expression and HPV genome copy number, and integrated state of the virus that may play a pivotal role in promotion/maintanence of tumorigenic phenotype.
Journal ArticleDOI
Tumor reversion: a dream or a reality.
Avantika Tripathi,Anjali Kashyap,Greesham Tripathi,Joni Yadav,Rakhi Bibban,Nikita Aggarwal,Kulbhushan Thakur,Arun Chhokar,Mohit Jadli,Ashok Kumar Sah,Ashok Kumar Sah,Yeshvandra Verma,Hatem Zayed,Amjad Husain,Alok C. Bharti,Manoj Kumar Kashyap,Manoj Kumar Kashyap +16 more
TL;DR: A review of tumor regression models using available genome-editing methods, followed by in vitro and in vivo proteomics profiling techniques show early evidence that tumor reversion will reveal a new wave of therapeutic discoveries that will significantly impact clinical practice in cancer therapy as mentioned in this paper.